BTSG
BrightSpring Health Services, Inc. · Healthcare · Health Information Services
Last
$47.13
+$1.33 (+2.91%) 2:44 PM ET
Prev close $45.80
Open $46.52
Day high $47.38
Day low $46.18
Volume 716,284
Avg vol 2,688,093
Mkt cap
$8.85B
P/E ratio
53.56
FY Revenue
$12.91B
EPS
0.88
Gross Margin
11.76%
Sector
Healthcare
AI report sections
BTSG
BrightSpring Health Services, Inc.
BrightSpring shows strong multi-period price appreciation and constructive technical momentum, with the share price trading near the upper end of its 52-week range. Fundamentally, the company combines solid revenue and earnings growth with positive free cash flow generation, offset by thin margins, elevated leverage, and a relatively high earnings multiple. Short interest and recent news flow appear balanced to mildly supportive, indicating engagement but not extreme positioning.
AI summarized at 6:23 PM ET, 2026-02-18
AI summary scores
INTRADAY: 63 SWING: 71 LONG: 66
Volume vs average
Intraday (cumulative)
−17% (Below avg)
Vol/Avg: 0.83×
RSI
60.74 (Strong)
Strong (60–70)
MACD momentum
Intraday
-0.01 (Weak)
MACD: -0.03 Signal: -0.02
Short-Term
+0.18 (Strong)
MACD: 1.27 Signal: 1.08
Long-Term
+0.27 (Strong)
MACD: 1.72 Signal: 1.45
Intraday trend score 68.69

Latest news

BTSG 12 articles Positive: 6 Neutral: 4 Negative: 2
Neutral Benzinga • Not Specified
BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita

BrightSpring Health Services has completed the sale of its ResCare Community Living division to Sevita, a leading provider of home and community-based specialty health care. The transaction, announced in January 2025, allows BrightSpring to focus on its core Provider Services division (Home Health Care, Personal Care, and Rehab Therapy) while Sevita expands its footprint to serve more individuals with intellectual and developmental disabilities.

BTSG BTSGU divestiture ResCare Community Living home and community-based care intellectual and developmental disabilities M&A healthcare services
Sentiment note

The sale represents a strategic refocusing of the company on its core Provider Services division. While divestiture typically signals a shift in business strategy, the company emphasizes continuity of care and operational stability, suggesting a deliberate and positive realignment rather than distress.

Neutral GlobeNewswire Inc. • Na
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase

BrightSpring Health Services announced a secondary offering of 20 million shares at $41.15 per share by existing stockholders including KKR affiliate and management members. The company will concurrently repurchase 1.46 million shares from the offering at the same price. No shares are being sold by BrightSpring itself, with all proceeds going to the Selling Stockholders. The offering is expected to close on March 4, 2026.

BTSG BTSGU secondary offering share repurchase stock offering KKR management stake reduction capital markets
Sentiment note

The secondary offering is a routine capital markets transaction where existing shareholders (including KKR) are liquidating portions of their holdings. While the company is repurchasing shares (typically positive), the large secondary offering by major shareholders could signal reduced confidence or portfolio rebalancing. The neutral sentiment reflects the transactional nature without clear positive or negative implications for the company's operations or fundamentals.

Neutral GlobeNewswire Inc. • Brightspring Health Services, Inc.
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase

BrightSpring Health Services announced a secondary offering of 15 million common stock shares by certain stockholders, including KKR, with no shares being sold by the company itself. The company will simultaneously repurchase 1.5 million shares from the underwriter.

BTSG BTSGU secondary offering stock repurchase BrightSpring KKR
Sentiment note

The company is conducting a standard secondary stock offering and share repurchase without significant positive or negative implications

Positive The Motley Fool • Jesterai
BrightSpring (BTSG) Q2 Revenue Jumps 29%

BrightSpring Health Services reported strong Q2 2025 financial results with revenue of $3,148 million, exceeding analyst estimates. The company saw significant growth in Pharmacy Solutions and Provider Services, with adjusted EPS increasing 266.7% year-over-year.

BTSG BTSGU CVS UNH healthcare pharmacy earnings home-based care
Sentiment note

Strong revenue growth of 29.1%, increased adjusted EPS from $0.06 to $0.22, raised full-year guidance, and demonstrated operational improvements in both Pharmacy Solutions and Provider Services segments

Neutral GlobeNewswire Inc. • N/A
BrightSpring Announces Pricing of Secondary Offering of Common Stock

BrightSpring Health Services, Inc. (NASDAQ: BTSG), a leading provider of home and community-based health services, announced the pricing of a secondary offering of 14,000,000 shares of its common stock by certain stockholders, including affiliates of Kohlberg Kravis Roberts & Co. L.P.

BTSG BTSGU BrightSpring Health Services secondary offering common stock
Sentiment note

The article is neutral towards BrightSpring Health Services, as it is simply announcing a secondary offering of its common stock by certain stockholders, without any indication of the company's performance or future prospects.

Positive GlobeNewswire Inc. • N/A
BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

BrightSpring Health Services, Inc. reported strong financial results for the first quarter of 2025, with revenue and adjusted EBITDA growth, and increased its full-year 2025 guidance.

BTSG BTSGU BrightSpring Health Services financial results guidance
Sentiment note

The company reported strong financial performance in Q1 2025, with revenue and adjusted EBITDA growth, and increased its full-year 2025 guidance, indicating a positive outlook for the business.

Positive Benzinga • Benzinga Editor
BrightSpring Health Divests Community Living Business For $850 Million To Focus On Core Activities

BrightSpring Health announced the divestiture of its Community Living business to Sevita for $835 million, allowing the company to focus on its core services and reduce debt. The transaction is expected to be accretive to the company's revenue and EBITDA growth.

BTSG BTSGU BrightSpring Health Sevita Community Living Divestiture Debt Reduction
Sentiment note

The divestiture of the Community Living business allows BrightSpring to focus on its core services, improve operational efficiencies, and reduce debt, which is expected to drive revenue and EBITDA growth.

Positive GlobeNewswire Inc. • N/A
BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living

BrightSpring Health Services, Inc. has entered into an agreement to sell its Community Living business to Sevita for $835 million. The divestiture will allow BrightSpring to focus on its core Provider Services segment, including home health, hospice, personal care, and rehabilitation services.

BTSG BTSGU BrightSpring Health Services Sevita Community Living Provider Services
Sentiment note

The divestiture of the Community Living business will allow BrightSpring to focus on its core Provider Services segment, which is expected to drive revenue and EBITDA growth. The transaction will also strengthen the company's balance sheet and reduce debt.

Positive GlobeNewswire Inc. • N/A
BrightSpring Health Services Announces Onco360® Has Been Selected as a Partner for Several New Drugs

BrightSpring Health Services' specialty pharmacy partner, Onco360, has been selected as the national pharmacy partner for multiple medications approved to treat advanced cancers and blood diseases, expanding available care options and extending the lives of many patients facing rare cancers and blood diseases.

BTSG BTSGU BrightSpring Health Services Onco360 cancer treatments blood disease treatments
Sentiment note

The article highlights BrightSpring Health Services' pride in its specialty pharmacy partner, Onco360, for being selected as the national pharmacy partner for multiple medications approved to treat advanced cancers and blood diseases. This suggests a positive sentiment towards BrightSpring Health Services.

Positive Benzinga • Globe Newswire
BrightSpring Health Services Announces Definitive Agreement to Acquire Haven Hospice, Expanding Hospice Services into Florida

BrightSpring Health Services, a leading provider of home and community-based health services, has announced the acquisition of Haven Hospice, a Florida-based hospice care provider. This expansion into Florida will allow BrightSpring to provide high-quality hospice services to more patients and their families.

BTSG BTSGU BrightSpring Health Services Haven Hospice Hospice Services Florida
Sentiment note

The article highlights BrightSpring's expansion into Florida through the acquisition of Haven Hospice, which will allow the company to provide high-quality hospice services to more patients and their families. This is seen as a positive move for the company's growth and service offerings.

Negative GlobeNewswire Inc. • N/A
Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, BrightSpring, Outset, and NuScale and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential issues with the financial statements of Paragon 28, BrightSpring Health Services, Outset Medical, and NuScale Power Corp.

FNA BTSG BTSGU OM Paragon 28 BrightSpring Health Services Outset Medical NuScale Power Corp.
Sentiment note

The company reported Q2 2024 earnings that missed consensus estimates, leading to an 8.75% drop in stock price.

Negative GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman, Llc
BrightSpring Health Services, Inc. (BTSG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BrightSpring Health Services, Inc. (BTSG) due to the company's financial results for the second quarter of 2024 missing consensus estimates.

BTSG BTSGU BrightSpring Health Services investigation financial results
Sentiment note

The article mentions that BrightSpring's stock price fell 8.75% after the company reported non-GAAP earnings per share that missed consensus estimates, indicating a negative sentiment towards the company's financial performance.

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal